By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ardea Biosciences, Inc. 

4939 Directors Place

San Diego  California  92121  U.S.A.
Phone: 858-652-6500 Fax: 858-652-0760




Company News
Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup 11/4/2014 12:20:55 PM
AstraZeneca PLC (AZN) and Ardea Biosciences, Inc. Release: A Large, Observational Study of Common Gout Treatment Allopurinol Shows Less Than Half of Patients Reach Recommended Treatment Goal 10/28/2013 10:13:36 AM
AstraZeneca PLC (AZN) Completes Acquisition of Ardea Biosciences, Inc. 6/20/2012 9:06:02 AM
Ardea Biosciences, Inc. Announces Expiration of HSR Waiting Period in Connection With Proposed Merger 6/5/2012 9:14:03 AM
Ardea Biosciences, Inc. Earns $7.5 Million Milestone From Bayer HealthCare (BAY) 5/30/2012 9:09:26 AM
Ardea Biosciences, Inc. Announces First Quarter 2012 Financial Results 5/7/2012 8:40:10 AM
Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. 4/25/2012 9:21:10 AM
AstraZeneca PLC (AZN) to Acquire Ardea Biosciences, Inc. for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout 4/23/2012 6:58:00 AM
Ardea Biosciences, Inc. Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2011 Financial Results 3/9/2012 8:31:19 AM
Ardea Biosciences, Inc. to Present at Upcoming Investor Conferences 2/29/2012 9:23:41 AM